Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Iii Harry John Cross > Profile

Iii Harry John Cross

Affiliations

  • Chief Financial Officer at Senti Biosciences Inc. (SNTI), 2025-03-11
  • Chief Financial Officer at Sonnet Biotherapeutics Holdings Inc. (SONN), 2024-12-06